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Dear Editor
The COVID-19 pandemic has presented a serious burden to
public health. Italy has been affected heavily, with nearly 2
million confirmed cases and almost 70 000 deaths. Globally,
healthcare authorities have restricted medical care to emer-
gency procedures, postponing elective surgical activity1–5. To
evaluate the impact of restrictions on surgical activity for thy-
roid cancers in Italy, the Italian Society of Endocrine Surgery
group and the Oncoteam of the Italian Society of Oncological
Surgery undertook a retrospective analysis, comparing activ-
ity during the first wave of the COVID-19 pandemic (from 9
March 2020 to 31 August 2020) with activity during the same
period of the previous year (control group). The study was reg-
istered at ClinicalTrials.gov (NCT04635813).
For this study, aggregated data were collected from 28
Italian surgical units, including patients who had undergone
thyroidectomy with a diagnosis of thyroid carcinoma during the
reference intervals. The main outcome of this study was the re-
duction in surgical activity for thyroid cancer. Features of the
neoplasms diagnosed, including tumour size and incidence of
lymph node metastases, extrathyroidal extension and multicen-
tricity, were also analysed, to identify any significant differences
between the two groups.
A total of 1570 patients with thyroid cancer were included
in the study; 662 patients with thyroid carcinoma had surgery
during the COVID-19 pandemic, and 908 during the same period
in the previous year. This represented a 27.1 per cent reduction in
the number of operations (Fig. 1). The mean(s.d.) number of
patients operated on per unit was 21.6(24.5) in 2020 and
23.6(21.6) in 2019 (P¼ 0.158). Mean nodule size tended to be larger
in the group that had surgery during the pandemic (18.4(13.5)
versus 17.2(12.6) mm; P¼ 0.071). The incidence of lymph node me-
tastases (21.5 per cent in 2020 versus 18.1 per cent in 2019;
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P¼ 0.107), extrathyroidal extension (14.7 versus 16.0 per cent;
P¼ 0.520), and multicentricity (29.5 versus 26.4 per cent; P ¼ 0.205)
did not differ between the two groups.
Overall, there was a reduction in thyroidectomies for thyroid
malignancies during the COVID-19 pandemic. This reduction
was, however, not significant, probably because elective surgery
was reserved for the most aggressive thyroid malignancies rather
than uncertain or benign thyroid disease during the most difficult
phases at the start of the pandemic. With the weakening of the
pandemic in the summer months, surgical activity was gradually
restored. A greater proportion of aggressive tumours was not ob-
served during the COVID-19 pandemic. Nevertheless, this aspect
should be monitored carefully because the delay in screening
programmes and planned examinations could lead to an increase
in missed diagnoses in the future, with an increased number of
aggressive tumours.
Considering the new escalation of the pandemic while this re-
port was being written, healthcare organizations are urged to en-
sure prompt treatment for thyroid malignancies, including
patients with suspicious nodules. The authors recommend not
delaying screening programmes and planned visits, which could
be moved to non-hospital settings.
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Fig. 1 Number of patients operated upon during 2019 and 2020, and
incidence of lymph node metastasis, extrthyroidal extension and
multicentric carcinoma.
Bars indicate number of patients and lines the incidence of lymph node
metastasis (LNM), extrathyroidal extension (ETE) and multicentric carcinoma
(MCC).






/bjs/article/108/4/e166/6154404 by guest on 17 M
ay 2021
